Abstract
In our increasingly interconnected world, it is crucial to understand the risk of an outbreak originating in one country or region and spreading to the rest of the world. Digital disease surveillance tools such as ProMED and HealthMap have the potential to serve as important early warning systems as well as complement the field surveillance during an ongoing outbreak. Here we present a flexible statistical model that uses data produced from digital surveillance tools (ProMED and HealthMap) to forecast short term incidence trends in a spatially explicit manner. The model was applied to data collected by ProMED and HealthMap during the 2013-2016 West African Ebola epidemic. The model was able to predict each instance of international spread 1 to 4 weeks in advance. Our study highlights the potential and limitations of using publicly available digital surveillance data for assessing outbreak dynamics in real-time.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The work in this manuscript was funded through the USAID (United States Agency of International Development) Center for Accelerating Innovation and Impact - "Combating Zika and Future Threats: A Grand Challenge for Development" Program (Award No. AID-0AA-F-16-00115). The contents of the manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the USAID. SB, AC and PN acknowledge joint Centre funding from the UK Medical Research Council and Department for International Development (MR/R015600/1), funding from the UK National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Modelling Methodology at Imperial College London in partnership with Public Health England (PHE) (HPRU-2012-10080), and funding from the Bill and Melinda Gates Foundation (OPP1092240).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data used in this study are available online.
https://github.com/sangeetabhatia03/mriids_manuscript/tree/v1.0
